Cannara Biotech Inc.
TSXV:LOVE.V
0.96 (CAD) • At close March 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) CAD.
| 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 26.586 | 25.07 | 23.036 | 19.545 | 19.683 | 19.483 | 18.331 | 15.84 | 13.036 | 10.312 | 11.791 | 10.064 | 7.422 | 6.565 | 6.235 | 7.159 | 2.258 | 1.368 | 0.585 | 0.764 | 0.668 | 0.533 | 0.553 | 0.507 | 0.518 | 0.518 |
| Cost of Revenue
| 14.631 | 14.892 | 12.584 | 12.587 | 15.543 | 11.248 | 8.434 | 7.343 | 8.774 | 5.479 | 4.844 | 5.315 | 4.407 | 6.89 | 1.956 | 2.74 | 0.163 | 0.285 | 1.046 | 0.048 | 0.198 | 0.034 | 0.048 | 0.221 | 0.082 | 0.053 |
| Gross Profit
| 11.956 | 10.179 | 10.453 | 6.958 | 4.14 | 8.235 | 9.897 | 8.498 | 4.262 | 4.833 | 6.947 | 4.749 | 3.016 | -0.325 | 4.28 | 4.419 | 2.095 | 1.083 | -0.461 | 0.716 | 0.47 | 0.5 | 0.505 | 0.286 | 0.437 | 0.466 |
| Gross Profit Ratio
| 0.45 | 0.406 | 0.454 | 0.356 | 0.21 | 0.423 | 0.54 | 0.536 | 0.327 | 0.469 | 0.589 | 0.472 | 0.406 | -0.05 | 0.686 | 0.617 | 0.928 | 0.792 | -0.788 | 0.937 | 0.703 | 0.937 | 0.913 | 0.564 | 0.842 | 0.899 |
| Reseach & Development Expenses
| 0.171 | 0.172 | 0.241 | 0.35 | 0.32 | 0.21 | 0.306 | 0.262 | 0.246 | 0.216 | 0.324 | 0.37 | 0.306 | 0.256 | 0.23 | 0.443 | 0.683 | 0.55 | 0.662 | 1.341 | 0.369 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 3.264 | 2.947 | 3.251 | 3.895 | 2.879 | 2.504 | 2.939 | 2.522 | 2.645 | 2.206 | 2.111 | 2.469 | 1.804 | 2.15 | 1.169 | 1.274 | 1.571 | 1.852 | 1.285 | 2.682 | 2.473 | 1.856 | 2.736 | 2.063 | 0.013 |
| Selling & Marketing Expenses
| 0 | 2.229 | 2.121 | 1.604 | 1.658 | 1.293 | 1.005 | 0.85 | 0.546 | 0.508 | 0.461 | 0.374 | 0.303 | 0.3 | 0.322 | 0.311 | 0.243 | 0.265 | 0.244 | 0.261 | 0.185 | 0.216 | 0.264 | 0.035 | 0.192 | 0.275 |
| SG&A
| 5.625 | 5.493 | 5.068 | 4.854 | 6.1 | 4.172 | 3.509 | 3.789 | 3.068 | 3.153 | 2.667 | 2.486 | 2.771 | 2.103 | 2.472 | 1.48 | 1.517 | 1.836 | 2.096 | 1.546 | 2.867 | 2.689 | 2.119 | 2.77 | 2.255 | 0.013 |
| Other Expenses
| 0 | 0.282 | 0.099 | -1.8 | 0 | 0 | 0 | 0 | 0.279 | 0.294 | 0.185 | 0.351 | 0.305 | 0.232 | 0.023 | 0.237 | 0.252 | 0.274 | 0.217 | 0.026 | 0.725 | 0.528 | 0.149 | 0.15 | 0.139 | 0 |
| Operating Expenses
| 6.078 | 5.947 | 5.408 | 3.404 | 6.1 | 4.791 | 3.996 | 4.215 | 3.593 | 3.664 | 3.176 | 3.206 | 3.382 | 2.592 | 2.725 | 2.16 | 2.452 | 2.661 | 2.975 | 2.919 | 3.96 | 3.218 | 2.268 | 2.921 | 2.394 | 0.013 |
| Operating Income
| 5.877 | 4.232 | 5.045 | 3.554 | -1.96 | 3.439 | 5.831 | 4.282 | 0.375 | 0.82 | 3.763 | 1.162 | -0.596 | -0.144 | 1.567 | 2.259 | -0.411 | -3.158 | -3.485 | -2.259 | -3.49 | -2.718 | -3.638 | -2.635 | -1.957 | -0.013 |
| Operating Income Ratio
| 0.221 | 0.169 | 0.219 | 0.182 | -0.1 | 0.176 | 0.318 | 0.27 | 0.029 | 0.08 | 0.319 | 0.115 | -0.08 | -0.022 | 0.251 | 0.316 | -0.182 | -2.308 | -5.955 | -2.957 | -5.221 | -5.097 | -6.576 | -5.2 | -3.776 | -0.024 |
| Total Other Income Expenses Net
| -1.148 | -1.198 | -1.245 | -1.531 | -1.487 | -1.331 | -1.2 | -1.354 | -1.249 | -1.14 | -1.209 | -0.106 | -0.773 | -0.547 | -0.435 | -0.562 | -0.452 | -0.337 | -0.424 | -0.248 | -0.247 | -0.223 | -0.194 | -0.187 | -2.054 | -0.313 |
| Income Before Tax
| 4.729 | 3.034 | 3.8 | 2.023 | -3.447 | 2.107 | 4.632 | 2.929 | -0.618 | 0.003 | 2.553 | 1.428 | -1.146 | -0.53 | 1.132 | 1.698 | -0.863 | -3.495 | -3.909 | -2.507 | -3.737 | -2.941 | -3.832 | -2.823 | -4.012 | -0.013 |
| Income Before Tax Ratio
| 0.178 | 0.121 | 0.165 | 0.104 | -0.175 | 0.108 | 0.253 | 0.185 | -0.047 | 0 | 0.217 | 0.142 | -0.154 | -0.081 | 0.182 | 0.237 | -0.382 | -2.555 | -6.679 | -3.282 | -5.591 | -5.515 | -6.926 | -5.57 | -7.738 | -0.024 |
| Income Tax Expense
| 1.415 | 0.728 | -1.955 | 0 | 3.447 | 1.059 | 0.33 | 1.165 | 0.024 | -0.047 | -0.057 | -0.66 | 0.176 | 0.396 | 0.43 | 0.426 | 0.381 | 0.329 | 0.262 | 0.192 | 0.145 | 0.115 | 0.128 | 0.118 | 0.241 | -0.417 |
| Net Income
| 3.315 | 2.306 | 5.754 | 2.023 | -3.447 | 2.107 | 4.632 | 2.929 | -0.642 | 0.049 | 2.553 | 2.089 | -1.322 | -0.927 | 1.132 | 1.698 | -0.863 | -3.495 | -3.86 | -2.375 | -3.529 | -2.719 | -3.577 | -2.554 | -3.878 | -0.013 |
| Net Income Ratio
| 0.125 | 0.092 | 0.25 | 0.104 | -0.175 | 0.108 | 0.253 | 0.185 | -0.049 | 0.005 | 0.217 | 0.208 | -0.178 | -0.141 | 0.182 | 0.237 | -0.382 | -2.555 | -6.594 | -3.109 | -5.28 | -5.099 | -6.465 | -5.04 | -7.481 | -0.024 |
| EPS
| 0.037 | 0.026 | 0 | 0.023 | -0.038 | 0.023 | 0.051 | 0.033 | -0.007 | 0.001 | 0.029 | 0.024 | -0.015 | -0.011 | 0.013 | 0.1 | -0.012 | -0.047 | -0.001 | -0.033 | -0.05 | -0.039 | -0.001 | -0.037 | -0.066 | -0 |
| EPS Diluted
| 0.036 | 0.025 | 0 | 0.022 | -0.038 | 0.023 | 0.051 | 0.033 | -0.007 | 0.001 | 0.029 | 0.024 | -0.015 | -0.011 | 0.013 | 0.1 | -0.012 | -0.047 | -0.001 | -0.033 | -0.05 | -0.039 | -0.001 | -0.037 | -0.066 | -0 |
| EBITDA
| 7.336 | 5.638 | 5.841 | 5.099 | -0.915 | 5.11 | 7.243 | 5.592 | 1.897 | 2.456 | 4.989 | 3.28 | -0.208 | 0.641 | 2.489 | 2.902 | 0.285 | -2.451 | -2.873 | -1.549 | -2.653 | -2.063 | -3.292 | -2.282 | -3.495 | -1.804 |
| EBITDA Ratio
| 0.276 | 0.225 | 0.254 | 0.261 | -0.046 | 0.262 | 0.395 | 0.353 | 0.146 | 0.238 | 0.423 | 0.326 | -0.028 | 0.098 | 0.399 | 0.405 | 0.126 | -1.792 | -4.909 | -2.028 | -3.97 | -3.869 | -5.95 | -4.504 | -6.741 | -3.48 |